Bianca Martins Estevão
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bianca Martins Estevão has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Valtencir Zucolotto
University of São Paulo
4 shared publications - Enrica Gianotti
Department for Sustainable Development and Ecological Transition, Università del Piemonte Orientale, Piazza Sant’Eusebio 5, 13100 Vercelli, Italy
2 shared publications - Ivana Miletto
Department of Pharmaceutical Sciences, University of Piemonte Orientale, Largo Guido Donegani 2/3, 28100 Novara, Italy
2 shared publications - Leonardo Marchese
Dipartimento di Scienze e Innovazione Tecnologica (DISIT), Università del Piemonte Orientale, Viale T. Michel 11, I-15121 Alessandria, Italy
2 shared publications - Nathalia Cristina Rissi
Nanomedicine and Nanotoxicology Group (GNano), São Carlos Institute of Physics, University of São Paulo, P.O. Box 369, 13566-590 São Carlos, São Paulo, Brazil
2 shared publications Andrea S.S. de Camargo
Laboratory of Spectroscopy of Functional Materials, São Carlos Institute of Physics, University of São Paulo, São Carlos, SP 13566-590, Brazil
1 shared publication
Latest Publications
- 5 August 2022
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 40, 103052
Mesoporous silica nanoparticles incorporated with Ir(III) complexes: From photophysics to photodynamic therapy
- 5 August 2022
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 40, 103052
Mesoporous silica nanoparticles incorporated with Ir(III) complexes: From photophysics to photodynamic therapy
- Open Access
- 14 December 2021
- Published by Wiley in ChemistryOpen
- Vol. 10 (12) , 1251-1259
Mesoporous Silica Nanoparticles Functionalized with Amino Groups for Biomedical Applications
The synthesis and characterization of amino‐functionalized mesoporous silica nanoparticles are presented following two different synthetic methods: co‐condensation and post‐synthesis grafting of 3‐aminopropyltriethoxysilane. The amino groups’ distribution on the mesoporous silica nanoparticles was evaluated considering the aggregation state of a grafted photosensitizer (Verteporfin) by using spectroscopic techniques. The homogeneous distribution of amino groups within the silica network is a key factor to avoid aggregation during further organic functionalization and to optimize the performance of functionalized silica nanoparticles in biomedical applications. In addition, the formation of a protein corona on the external surface of both bare and amino‐functionalized mesoporous silica was also investigated by adsorbing Bovine Serum Albumin (BSA) as a model protein. The adsorption of BSA was found to be favorable, reducing the aggregation phenomena for both bare and amino‐modified nanoparticles. Nevertheless, the dispersant effect of BSA was much more evident in the case of amino‐modified nanoparticles, which reached monodispersion after adsorption of the protein, thus suggesting that amino‐modified nanoparticles can benefit from protein corona formation for preventing severe aggregation in biological media.
- 14 December 2021
- Published by Wiley in ChemistryOpen
- Vol. 10 (12) , 1251-1259
Open AccessMesoporous Silica Nanoparticles Functionalized with Amino Groups for Biomedical Applications
The synthesis and characterization of amino‐functionalized mesoporous silica nanoparticles are presented following two different synthetic methods: co‐condensation and post‐synthesis grafting of 3‐aminopropyltriethoxysilane. The amino groups’ distribution on the mesoporous silica nanoparticles was evaluated considering the aggregation state of a grafted photosensitizer (Verteporfin) by using spectroscopic techniques. The homogeneous distribution of amino groups within the silica network is a key factor to avoid aggregation during further organic functionalization and to optimize the performance of functionalized silica nanoparticles in biomedical applications. In addition, the formation of a protein corona on the external surface of both bare and amino‐functionalized mesoporous silica was also investigated by adsorbing Bovine Serum Albumin (BSA) as a model protein. The adsorption of BSA was found to be favorable, reducing the aggregation phenomena for both bare and amino‐modified nanoparticles. Nevertheless, the dispersant effect of BSA was much more evident in the case of amino‐modified nanoparticles, which reached monodispersion after adsorption of the protein, thus suggesting that amino‐modified nanoparticles can benefit from protein corona formation for preventing severe aggregation in biological media.
- 20 September 2021
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 3 (10) , 5061-5072
Orange Trunk Waste-Based Lignin Nanoparticles Encapsulating Curcumin as a Photodynamic Therapy Agent against Liver Cancer
- 20 September 2021
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 3 (10) , 5061-5072
Orange Trunk Waste-Based Lignin Nanoparticles Encapsulating Curcumin as a Photodynamic Therapy Agent against Liver Cancer
- 8 September 2021
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 4 (9) , 9779-9789
Doped Plasmonic Zinc Oxide Nanoparticles with Near-Infrared Absorption for Antitumor Activity
- 8 September 2021
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 4 (9) , 9779-9789
Doped Plasmonic Zinc Oxide Nanoparticles with Near-Infrared Absorption for Antitumor Activity
- Open Access
- 14 June 2021
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 2 (15) , 5224-5235
Anti-GPC1-modified mesoporous silica nanoparticles as nanocarriers for combination therapy and targeting of PANC-1 cells
We present a novel therapeutic nanoplatform based on mesoporous silica nanoparticles encapsulating ferulic acid/gemcitabine and functionalized with anti-GPC1 antibodies to target human pancreatic cancer (PANC-1) cells. This dynamic nanoplatform has been designed for enhanced cellular selectivity and improved antitumor therapy. The well-ordered mesoporous silica nanoparticles were confirmed through structural and morphological analyses, which revealed nanoparticles with sizes in the range from 100 to 120 nm. X-ray diffraction analyses revealed an ordered hexagonal lattice with typical mesopores of the MCM41 material. The functionalization of silica nanoparticles with anti-GPC1 antibodies allowed the improved targeting and simultaneous delivery of gemcitabine and ferulic acid to PANC-1 cells. Our results showed that the combination therapy was more efficient than the use of isolated conventional drugs, increasing the effectiveness of MSNs on carcinogenic cells and opening the door for future in vivo studies.
- 14 June 2021
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 2 (15) , 5224-5235
Open AccessAnti-GPC1-modified mesoporous silica nanoparticles as nanocarriers for combination therapy and targeting of PANC-1 cells
We present a novel therapeutic nanoplatform based on mesoporous silica nanoparticles encapsulating ferulic acid/gemcitabine and functionalized with anti-GPC1 antibodies to target human pancreatic cancer (PANC-1) cells. This dynamic nanoplatform has been designed for enhanced cellular selectivity and improved antitumor therapy. The well-ordered mesoporous silica nanoparticles were confirmed through structural and morphological analyses, which revealed nanoparticles with sizes in the range from 100 to 120 nm. X-ray diffraction analyses revealed an ordered hexagonal lattice with typical mesopores of the MCM41 material. The functionalization of silica nanoparticles with anti-GPC1 antibodies allowed the improved targeting and simultaneous delivery of gemcitabine and ferulic acid to PANC-1 cells. Our results showed that the combination therapy was more efficient than the use of isolated conventional drugs, increasing the effectiveness of MSNs on carcinogenic cells and opening the door for future in vivo studies.
- 1 June 2017
- Published by American Scientific Publishers in Advanced Science Letters
- Vol. 23 (6) , 5837-5840
Mesoporous Silica Nanoparticles-Based Nanoplatforms for Photodynamic Therapy
Highly efficient nanoplatforms for photodynamic therapy were obtained by covalent conjugation of verteporfin (Ver) and Rose Bengal (RB) within mesoporous silica nanoparticles. Hosting of the photosensitizers (PS) into mesoporous silica nanoparticles allowed overcoming their specific limitations, such as hydrophobicity of Ver, which causes its aggregation in aqueous media, and hydrophilicity of RB, which limits their uptake by target cells. PS loading, dispersion and efficiency in the photoproduction and delivery of singlet oxygen (1O2) were carefully evaluated. In vitro tests have evidenced that the optimized nanoplatforms are able to largely reduce the proliferation of different cell lines, including in the high malignancy melanoma cellular model (SK-MEL-28).
- 1 June 2017
- Published by American Scientific Publishers in Advanced Science Letters
- Vol. 23 (6) , 5837-5840
Mesoporous Silica Nanoparticles-Based Nanoplatforms for Photodynamic Therapy
Highly efficient nanoplatforms for photodynamic therapy were obtained by covalent conjugation of verteporfin (Ver) and Rose Bengal (RB) within mesoporous silica nanoparticles. Hosting of the photosensitizers (PS) into mesoporous silica nanoparticles allowed overcoming their specific limitations, such as hydrophobicity of Ver, which causes its aggregation in aqueous media, and hydrophilicity of RB, which limits their uptake by target cells. PS loading, dispersion and efficiency in the photoproduction and delivery of singlet oxygen (1O2) were carefully evaluated. In vitro tests have evidenced that the optimized nanoplatforms are able to largely reduce the proliferation of different cell lines, including in the high malignancy melanoma cellular model (SK-MEL-28).